306
Participants
Start Date
April 9, 2015
Primary Completion Date
June 16, 2016
Study Completion Date
March 6, 2020
ceritinib
The investigational drug ceritinib was supplied to the Investigators as 150 mg capsules, for oral administration.
Novartis Investigative Site, Taipei
Novartis Investigative Site, Vienna
Novartis Investigative Site, Sofia
Novartis Investigative Site, Edegem
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Pulau Pinang
Novartis Investigative Site, Berlin
Novartis Investigative Site, Donostia / San Sebastian
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Maryland Oncology Hematology, P.A. SC-2, Rockville
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Brescia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Novara
Novartis Investigative Site, Madrid
Greenville Health System SC, Greenville
Novartis Investigative Site, Pamplona
Novartis Investigative Site, Aviano
Novartis Investigative Site, Taoyuan District
Novartis Investigative Site, Verona
Novartis Investigative Site, Talas / Kayseri
Novartis Investigative Site, Bologna
Novartis Investigative Site, Taichung
Novartis Investigative Site, Seville
Goshen Center for Cancer Care IU Health - SC, Indianapolis
Novartis Investigative Site, Meldola
Novartis Investigative Site, Cologne
Novartis Investigative Site, Brno
Novartis Investigative Site, San Giovanni Rotondo
Highlands Oncology Group, Fayetteville
Utah Cancer Specialists Dept.of Utah Cancer Spec. (3), Salt Lake City
Novartis Investigative Site, Hat Yai
Loma Linda University, Loma Linda
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Kuching
Novartis Investigative Site, Würzburg
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Nashik
Novartis Investigative Site, Kolkata
Essex Oncology of North Jersey PA SC, Belleville
Novartis Investigative Site, Grafton
Novartis Investigative Site, Auckland
Novartis Investigative Site, Montería
Novartis Investigative Site, Vienna
Novartis Investigative Site, Natal
Novartis Investigative Site, Passo Fundo
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, Itajaí
Novartis Investigative Site, Barretos
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Toronto
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Bangalore
Novartis Investigative Site, Delhi
Novartis Investigative Site, Roma
Novartis Investigative Site, Nieuwegein
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Konin
Novartis Investigative Site, Tarnobrzeg
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Metropolitan Borough of Wirral
Novartis Investigative Site, Newcastle upon Tyne
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY